Article Details

DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance

Retrieved on: 2025-03-20 21:39:56

Tags for this article:

Click the tags to see associated articles and topics

DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance. View article details on hiswai:

Excerpt

It is not a chemotherapy drug but a human IgG1k monoclonal antibody that binds strongly to the CD38 molecule, which is highly expressed in multiple ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo